100% French Equities – Thursday, December 11, 2025

CAC 40 PREOPEN: 8018 points (+0.11%)

Key Stocks of the Day

EssilorLuxottica (EL): Announced a collaboration with the Chips-IT Foundation to develop connected glasses.

Sanofi (SAN): Two treatments (Qfitlia and Cablivi) receive approval in China for rare hematological diseases.

Aéroports de Paris (ADP): Announces a massive investment plan of €8.4 billion between 2027 and 2034.

Valneva (VLA): Positive phase II results for its chikungunya vaccine in children.

Icade (ICAD): Finalizes the sale of its Italian healthcare portfolio to BNP Paribas REIM for €173 million.

Exosens: Historic contract won with Theon for 100,000 Mikron binoculars, valued at €500 million.

Argan (ARG): Acquires 100,000 m² of warehouses occupied by Ferrero and Puma.

Nexity (NXI): Partners with GSE to enter the data center market.

Forsee Power (FORSE): Its battery system will be used by Mexican integrator MegaFlux for heavy vehicles.

Roctool (ALROC): Receives a €6 million order in the defense sector.

Genfit (GNFT): Promising antitumor activity for GNS561 in combination therapy.

Predilife (ALPRE): Raises €0.8 million via OCEANE 2030, funding secured until May 2026.

Figeac Aéro (FGA): Despite solid half-year results, the stock dropped by -7.23% yesterday. The group remains confident in its Pilot 28 plan.

Company Results Expected Today

Analyst Recommendations (French companies only)

**Recommendation Changes**

Upgrades

EssilorLuxottica (EL) → Citi maintains Buy, target raised to €339 (vs €296).

Engie (ENGI) → Jefferies remains at Buy, target raised to €25.70 (vs €22).

Pernod Ricard (RI) → Barclays upgrades to Overweight, target raised to €102 (vs €92).

Neutral

LVMH (MC) → Barclays remains at Market Weight, target raised to €580 (vs €560).

Solvay (SOLB) → Citi maintains Neutral, target lowered to €26 (vs €27).

Downgrades

No French company affected by a downgrade today.

Sylvain Mouilhaud – Equity Coach.